raltegravir

Once-daily raltegravir not as effective

Graham Stocks — Thu, 24 Feb 2011 17:57:08 -0800

Merck has terminated a trial comparing once-daily dosing against the currently recommended twice-daily dosing of raltegravir.

Raltegravir approved for first line

Graham Stocks — Thu, 02 Sep 2010 17:58:15 -0700

The Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. (PBS) has broadened access to raltegravir (Isentress) beyond treatment-experienced adults.

Raltegravir is now also available for people who are first starting HIV treatment.

Raltegravir + Truvada is now one of four preferred commencing regimens in the Australian HIV Treatment Guidelines.

News from IAS 2010

Graham Stocks — Wed, 01 Sep 2010 22:09:07 -0700

Adrian Ogier gives a round up of treatments news from the Vienna Conference.

Treatments news from the IAS Conference

Wed, 19 Aug 2009 18:52:42 -0700

A roundup of HIV treatments developments from the IAS Conference in Cape Town.

Treatment news from CROI

Paul Kidd — Thu, 12 Mar 2009 17:35:40 -0700

John Daye reports on treatments developments from the 16th Conference on Retroviruses and Opportunistic Infections (CROI) in Montréal, Canada.

New HIV treatments welcome

Sun, 30 Nov 2008 06:00:01 -0800

The listing of two new HIV treatment options on the Pharmaceutical Benefits Scheme[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. (PBS) is good news for people living with HIV, the National Association of People Living with HIV/AIDS (NAPWA) has said.

AIDS 2008: Is the HIV drug pipeline drying up?

David Menadue — Tue, 23 Sep 2008 19:21:56 -0700

The International AIDS Conference heard promising reports about the newer HIV treatments designed to help treat people with advanced and drug-resistantHIV which has mutated and is less susceptible to the effects of one or more anti-HIV drugs is said to be resistant. HIV, all of which are now available in Australia.

IAS 2007: Promising signs

Paul Kidd — Sun, 14 Oct 2007 07:10:00 -0700

A major HIV/AIDS medical conference in Sydney has generated lots of news on the treatments front, reports Paul Kidd.

CROI 2007: A great leap forward

Paul Kidd — Wed, 21 Mar 2007 07:10:12 -0700

A major scientific conference on HIV has wound up with promising news on treatments which could signal a significant improvement in HIV treatment for the first time in some years.

New tricks

Wed, 20 Dec 2006 06:06:45 -0800

Two new drugs have recently become available through the Special Access SchemeBefore a drug has been approved, manufacturers often provide the drug free of charge to people who cannot participate in a clinical trial and who meet certain criteria under a Special Access Scheme (SAS). , providing people with limited treatment options two important new possibilities. KIRSTY MACHON reports.